Be the first to like this
BriClone is an additive to cloning medium used in the post-fusion stages of hybridoma production for improving the efficiency of hybridoma cell cloning. It is manufactured by scientists on-site at the publicly-funded National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
Briclone is used in the generation of antibodies using hybridoma technology. These antibodies are used in a wide range of applications, including Cancer, Virology, Diagnostics, Parasitology, Pathology, Chemistry, Chemical Engineering, Veterinary research, Pharmacology, Toxicology, Jaundice, Pharmacokinetics, Dentistry, Biopharma, Neuroscience, Cardiology, Agriculture & Biological Sciences and mAb-generation Method development.
Briclone has been referenced in 85 peer-reviewed publications; the analysis presented here (using SCOPUS; www.scopus.com) was carried out on just the 77 papers published in English and publicly accessible.
For a full list of peer-reviewed Articles and Patents that reference Briclone, visit our website at www.nicb.ie/briclone or email email@example.com